Both contain semaglutide—but Ozempic is primarily for type 2 diabetes care, while Wegovy is for chronic weight management. Take the quiz to find the best next step (testing, consult, or program options).
Ozempic and Wegovy both contain semaglutide, but they’re approved and used differently. In general, Ozempic is used for type 2 diabetes management, while Wegovy is approved for chronic weight management in eligible adults. Wegovy also has an indication related to reducing certain cardiovascular risks in specific adults with overweight/obesity and established cardiovascular disease.
If you’re deciding between them, the “right” option depends on your health goals, medical history, and what a provider determines is appropriate.
What they have in common
Key differences
For many people seeking weight management support, Wegovy is the branded semaglutide option specifically approved for that purpose. Ozempic is commonly discussed online for weight loss, but its core approval is for type 2 diabetes care. A provider can help clarify options based on your goals and eligibility.
Best next step: take the quiz to see whether you should start with labs, a provider consult, or a program pathway.
The most common side effects with semaglutide are gastrointestinal.
Many people reduce discomfort by:
If symptoms are severe or persistent, you should reach out to a clinician promptly.
GLP-1 medications aren’t right for everyone. Eligibility depends on your medical history and risk factors, and a provider should review any contraindications or warning signs. If you have severe symptoms, signs of dehydration, or anything urgent, seek immediate medical care.
Most people do best starting with one of these: